← Back to recalls

Medline Convenience Kits: 1) DYNJ905503F, Model Number: CV ANESTHESIA - ROOM SET UP; 2) DYNJ905503G, Model Number: CV ANESTHESIA - ROOM SET UP

Class I
Recalling firm
Medline Industries, LP
Reason for recall
The Medline Convenience Kits contain Arrow Kits and Sets that include Lidocaine Hydrochloride Injection, USP and Bupivacaine Hydrochloride in Dextrose Injection, USP which were recalled due to quality issues identified during a recent FDA inspection of the supplier.
Affected products (lot / model / serial)
1) DYNJ905503F, UDI-DI: 10193489967272(each), 40193489967273(case), Lot Number: 24GBR740; 2) DYNJ905503F, UDI-DI: 10193489967272(each), 40193489967273(case), Lot Number: 24JBP984; 3) DYNJ905503G, UDI-DI: 10198459200397(each), 40198459200398(case), Lot Number: 26DBJ110; 4) DYNJ905503G, UDI-DI: 10198459200397(each), 40198459200398(case), Lot Number: 25ABJ069; 5) DYNJ905503G, UDI-DI: 10198459200397(each), 40198459200398(case), Lot Number: 25ABL749; 6) DYNJ905503G, UDI-DI: 10198459200397(each), 40198459200398(case), Lot Number: 25CBB762; 7) DYNJ905503G, UDI-DI: 10198459200397(each), 40198459200398(case), Lot Number: 25DBG799; 8) DYNJ905503G, UDI-DI: 10198459200397(each), 40198459200398(case), Lot Number: 25EBM994; 9) DYNJ905503G, UDI-DI: 10198459200397(each), 40198459200398(case), Lot Number: 25GBW226; 10) DYNJ905503G, UDI-DI: 10198459200397(each), 40198459200398(case), Lot Number: 25LBA950; 11) DYNJ905503G, UDI-DI: 10198459200397(each), 40198459200398(case), Lot Number: 25LBT019; 12) DYNJ905503G, UDI-DI: 10198459200397(each), 40198459200398(case), Lot Number: 26ABH519; 13) DYNJ905503G, UDI-DI: 10198459200397(each), 40198459200398(case), Lot Number: 26ABT315; 14) DYNJ905503G, UDI-DI: 10198459200397(each), 40198459200398(case), Lot Number: 26BBQ338
Units affected
227 units
Distribution pattern
US Nationwide.
Firm location
Northfield, IL, United States
Recall type
Voluntary: Firm initiated
How the firm notified customers
Letter
Product type
Devices
Status
Ongoing
Recall number
Z-2452-2026
Recall initiated
May 6, 2026
FDA classification date
June 24, 2026
FDA report date
July 1, 2026
FDA event ID
99043
Last updated on HTM Vibe
July 23, 2026
View on openFDA